Serum Ige High Immunotherapy

Human Serum Specific IgE ELISA Kit

MBS3803311-10x96StripWells 10x96-Strip-Wells
EUR 6725

Ige Serum Laboratories manufactures the serum ige high immunotherapy reagents distributed by Genprice. The Serum Ige High Immunotherapy reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact IgE Serum. Other Serum products are available in stock. Specificity: Serum Category: Ige Group: High Immunotherapy

True Blue

50mg Ask for price
Description: True Blue

True Blue

5mg Ask for price
Description: True Blue

Mouse OVA-Specific Serum IgE ELISA Kit

10x96-Strip-Wells
EUR 3955

Mouse OVA-Specific Serum IgE ELISA Kit

48-Strip-Wells
EUR 305

Mouse OVA-Specific Serum IgE ELISA Kit

5x96-Strip-Wells
EUR 2005

Mouse OVA-Specific Serum IgE ELISA Kit

96-Strip-Wells
EUR 475

High affinity IgE receptor subunit gamma Antibody

100 µl
EUR 162.5

High Immunotherapy information

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4380959-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4380959-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4380959-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4380959-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4380959-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4380960-05mL 0.5mL
EUR 405

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4380960-5x05mL 5x0.5mL
EUR 1725

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4381697-05mL 0.5mL
EUR 405

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4381697-5x05mL 5x0.5mL
EUR 1725

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4381718-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4381718-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4381718-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4381718-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

MBS4381718-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

MAGE-1 (Target for Cancer Immunotherapy); Clone MA454 (Concentrate)

RA0201-C.1 0.1 ml
EUR 60.07

MAGE-1 (Target for Cancer Immunotherapy); Clone MA454 (Concentrate)

RA0201-C.5 0.5 ml
EUR 200.66

MAGE-1 (Target for Cancer Immunotherapy); Clone SPM282 (Concentrate)

RA0576-C.1 0.1 ml
EUR 60.07